 In 2000, Solbec Pharmaceuticals Ltd. licensed the intellectual property rights to BEC from Cham and after it displayed good results against peritoneal mesothelioma in animals.Solbec initiated human trials which also yielded encouraging results.Other researchers have also demonstrated antiproliferative activity of steroidal glycosides against cancer cells.